Affinity Technologies today announced strategic actions to cut $4 million in annual costs at its subsidiary CAP/CLIA ...
It may be possible to predict diagnostic transition to schizophrenia and bipolar disorder from machine learning models.
Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot (DBS) Test in the U.S., an ...
Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six ...
According to WHO, cognitive health, in particular, is the ability to think, learn, and remember and is crucial for ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Genomenon, a leader in genomic intelligence, today announced the launch of an enhanced AI-powered integration for its Mastermind Genomic Intelligence Platform. This new capability further refines ...
CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback